Inhibrx Biosciences(INBX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

INBX Inhibrx Biosciences

盘后交易 11-26 18:18:33 EST

15.45

+0.59

+3.97%

盘后15.45

+0.000.00%

16:02 EST

最高15.58	最低14.56	成交量4.54万
今开14.71	昨收14.86	日振幅6.89%
总市值2.24亿	流通市值1.19亿	总股本1,448万
成交额69.15万	换手率0.59%	流通股本767.81万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"INBX","market":"US","secType":"STK","nameCN":"Inhibrx Biosciences","latestPrice":15.45,"timestamp":1732654800000,"preClose":14.86,"halted":0,"volume":45414,"hourTrading":{"tag":"盘后","latestPrice":15.45,"preClose":15.45,"latestTime":"16:02 EST","volume":1909,"amount":29494.05,"timestamp":1732654961145},"delay":0,"floatShares":7678078,"shares":14475904,"eps":119.38239,"marketStatus":"盘后交易","marketStatusCode":4,"change":0.59,"latestTime":"11-26 18:18:33 EST","open":14.71,"high":15.5839,"low":14.56,"amount":691477.65126,"amplitude":0.068903,"askPrice":17.38,"askSize":44,"bidPrice":13.73,"bidSize":100,"shortable":3,"etf":0,"ttmEps":119.38239,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1732669200000},"adr":0,"adjPreClose":14.86,"postHourTrading":{"tag":"盘后","latestPrice":15.45,"preClose":15.45,"latestTime":"16:02 EST","volume":1909,"amount":29494.05,"timestamp":1732654961145},"volumeRatio":0.500414,"impliedVol":0.6966,"impliedVolPercentile":0.633},"requestUrl":"/m/hq/s/INBX/wiki","defaultTab":"wiki","newsList":[{"id":"2486038823","title":"Inhibrx Biosciences, Inc.股价上涨11.65% 市值涨2651.09万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486038823","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486038823?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:32","pubTimestamp":1732545158,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时32分，Inhibrx Biosciences, Inc.股票出现波动，股价快速拉升11.65%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.97%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，利用其专有的模块化蛋白质工程平台开发了一系列新型生物治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223238abddfa59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223238abddfa59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INBX","BK4139"],"gpt_icon":0},{"id":"2485329878","title":"Inhibrx Biosciences, Inc.2024财年第三财季实现净利润-43.86百万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485329878","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485329878?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:03","pubTimestamp":1732291438,"startTime":"0","endTime":"0","summary":"11月23日，Inhibrx Biosciences, Inc.公布财报，公告显示公司2024财年第三财季净利润为-43.86百万美元；其中营业收入为0.00美元，每股基本收益为-3.03美元。从资产负债表来看，Inhibrx Biosciences, Inc.总负债44.10百万美元，其中短期债务1.84百万美元，资产负债比为0.06，流动比率为0.05。机构评级：截至2024年11月23日，当前有1家机构对Inhibrx Biosciences, Inc.目标价做出预测，其中目标均价为15.00美元，其中最低目标价为15.00美元，最高目标价为15.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000434abd7b9b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000434abd7b9b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INBX"],"gpt_icon":0},{"id":"2484978281","title":"Inhibrx Biosciences, Inc.盘中异动 股价大涨5.84%报14.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484978281","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484978281?lang=zh_cn&edition=full","pubTime":"2024-11-20 01:25","pubTimestamp":1732037127,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日01时25分，Inhibrx Biosciences, Inc.股票出现波动，股价快速上涨5.84%。截至发稿，该股报14.42美元/股，成交量2.6581万股，换手率0.18%，振幅6.98%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为1.26%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，利用其专有的模块化蛋白质工程平台开发了一系列新型生物治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120012527a2463cd8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120012527a2463cd8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INBX"],"gpt_icon":0},{"id":"2483307303","title":"Inhibrx Biosciences, Inc.盘中异动 临近收盘急速下挫5.24%报14.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483307303","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483307303?lang=zh_cn&edition=full","pubTime":"2024-11-15 04:50","pubTimestamp":1731617413,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日04时50分，Inhibrx Biosciences, Inc.股票出现波动，股价快速下跌5.24%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为2.09%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，利用其专有的模块化蛋白质工程平台开发了一系列新型生物治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115045013971a6a2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115045013971a6a2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INBX","BK4139"],"gpt_icon":0},{"id":"2483868381","title":"Inhibrx Biosciences, Inc.盘中异动 临近收盘股价大跌5.01%报15.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483868381","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483868381?lang=zh_cn&edition=full","pubTime":"2024-11-14 04:48","pubTimestamp":1731530939,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日04时48分，Inhibrx Biosciences, Inc.股票出现波动，股价快速下跌5.01%。截至发稿，该股报15.75美元/股，成交量2.2355万股，换手率0.15%，振幅6.16%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.53%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，利用其专有的模块化蛋白质工程平台开发了一系列新型生物治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114044859971a65f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114044859971a65f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INBX","BK4139"],"gpt_icon":0},{"id":"2478548421","title":"Inhibrx Biosciences, Inc.盘中异动 早盘大幅拉升5.09%报16.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478548421","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478548421?lang=zh_cn&edition=full","pubTime":"2024-10-28 22:22","pubTimestamp":1730125361,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日22时22分，Inhibrx Biosciences, Inc.股票出现异动，股价急速拉升5.09%。截至发稿，该股报16.15美元/股，成交量5087股，换手率0.04%，振幅2.78%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，利用其专有的模块化蛋白质工程平台开发了一系列新型生物治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028222241a1f2692f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028222241a1f2692f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INBX"],"gpt_icon":0},{"id":"2476704127","title":"Inhibrx Biosciences, Inc.盘中异动 早盘大幅上涨6.05%报17.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476704127","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476704127?lang=zh_cn&edition=full","pubTime":"2024-10-17 21:31","pubTimestamp":1729171866,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日21时31分，Inhibrx Biosciences, Inc.股票出现异动，股价大幅上涨6.05%。截至发稿，该股报17.02美元/股，成交量839股，换手率0.01%，振幅0.00%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，利用其专有的模块化蛋白质工程平台开发了一系列新型生物治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017213109971a0d44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017213109971a0d44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INBX"],"gpt_icon":0},{"id":"2473477564","title":"Inhibrx Biosciences, Inc.盘中异动 股价大涨5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473477564","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473477564?lang=zh_cn&edition=full","pubTime":"2024-10-08 23:40","pubTimestamp":1728402010,"startTime":"0","endTime":"0","summary":"北京时间2024年10月08日23时40分，Inhibrx Biosciences, Inc.股票出现异动，股价大幅拉升5.37%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.19%。其相关个股中，Bio-Path Holdings, Inc.、Portage Biotech Inc.、Capricor Therapeutics, Inc.涨幅较大，Aditxt, Inc.、Bio-Path Holdings, Inc.、Gri Bio, Inc.较为活跃，换手率分别为2376.11%、2291.88%、248.98%，振幅较大的相关个股有Virios Therapeutics, Inc.、Trevena, Inc.、Bio-Path Holdings, Inc.，振幅分别为46.27%、42.80%、39.93%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，利用其专有的模块化蛋白质工程平台开发了一系列新型生物治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100823401098e3b368&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100823401098e3b368&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INBX"],"gpt_icon":0},{"id":"2469756826","title":"Inhibrx Biosciences, Inc.盘中异动 临近午盘股价大跌5.09%报16.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469756826","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469756826?lang=zh_cn&edition=full","pubTime":"2024-09-20 23:56","pubTimestamp":1726847799,"startTime":"0","endTime":"0","summary":"北京时间2024年09月20日23时56分，Inhibrx Biosciences, Inc.股票出现波动，股价大幅下跌5.09%。截至发稿，该股报16.60美元/股，成交量3.2186万股，换手率0.22%，振幅3.77%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为2.29%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，利用其专有的模块化蛋白质工程平台开发了一系列新型生物治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920235639a1db78a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920235639a1db78a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INBX"],"gpt_icon":0},{"id":"2459471623","title":"Inhibrx Biosciences, Inc.盘中异动 股价大涨5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459471623","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459471623?lang=zh_cn&edition=full","pubTime":"2024-08-15 23:12","pubTimestamp":1723734727,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日23时12分，Inhibrx Biosciences, Inc.股票出现波动，股价快速上涨5.45%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.95%。其相关个股中，Cingulate Inc.、Tempest Therapeutics, Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Cingulate Inc.、Scisparc Ltd.、Altamira Therapeutics Ltd.较为活跃，换手率分别为6432.21%、2059.14%、572.98%，振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Tempest Therapeutics, Inc.、Cingulate Inc.，振幅分别为103.98%、79.83%、70.46%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，利用其专有的模块化蛋白质工程平台开发了一系列新型生物治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815231207ab5ddbf1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815231207ab5ddbf1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INBX","BK4139"],"gpt_icon":0},{"id":"2458986590","title":"Inhibrx Biosciences, Inc.盘中异动 早盘股价大涨6.16%报11.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458986590","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458986590?lang=zh_cn&edition=full","pubTime":"2024-08-12 21:38","pubTimestamp":1723469882,"startTime":"0","endTime":"0","summary":"北京时间2024年08月12日21时38分，Inhibrx Biosciences, Inc.股票出现异动，股价急速拉升6.16%。截至发稿，该股报11.72美元/股，成交量1360股，换手率0.01%，振幅0.00%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.57%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，利用其专有的模块化蛋白质工程平台开发了一系列新型生物治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812213802959297e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812213802959297e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INBX","BK4139"],"gpt_icon":0},{"id":"2457023113","title":"Inhibrx Biosciences, Inc.盘中异动 急速上涨11.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457023113","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457023113?lang=zh_cn&edition=full","pubTime":"2024-08-06 21:31","pubTimestamp":1722951067,"startTime":"0","endTime":"0","summary":"北京时间2024年08月06日21时31分，Inhibrx Biosciences, Inc.股票出现波动，股价快速上涨11.50%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。其相关个股中，Vbi Vaccines, Inc.、Tenax Therapeutics, Inc.、Sangamo Therapeutics, Inc.涨幅较大，Tenax Therapeutics, Inc.、Vbi Vaccines, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为653.90%、246.05%、200.27%，振幅较大的相关个股有Vbi Vaccines, Inc.、Cingulate Inc.、Cocrystal Pharma, Inc.，振幅分别为31.80%、10.37%、9.17%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，利用其专有的模块化蛋白质工程平台开发了一系列新型生物治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806213107941fe9e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806213107941fe9e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INBX","BK4139"],"gpt_icon":0},{"id":"2457779253","title":"Inhibrx Biosciences, Inc.盘中异动 早盘大幅下跌5.06%报13.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457779253","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457779253?lang=zh_cn&edition=full","pubTime":"2024-08-05 22:16","pubTimestamp":1722867418,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日22时16分，Inhibrx Biosciences, Inc.股票出现异动，股价快速跳水5.06%。截至发稿，该股报13.51美元/股，成交量2736股，换手率0.02%，振幅2.32%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为2.61%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，拥有一系列新型生物治疗候选药物，这些药物是使用其专有的模块化蛋白质工程平台而被开发出来的。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080522165998e34c1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080522165998e34c1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INBX"],"gpt_icon":0},{"id":"2456558792","title":"Inhibrx Biosciences, Inc.盘中异动 大幅跳水5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456558792","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456558792?lang=zh_cn&edition=full","pubTime":"2024-08-03 01:40","pubTimestamp":1722620442,"startTime":"0","endTime":"0","summary":"北京时间2024年08月03日01时40分，Inhibrx Biosciences, Inc.股票出现异动，股价大幅下挫5.15%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为1.54%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，拥有一系列新型生物治疗候选药物，这些药物是使用其专有的模块化蛋白质工程平台而被开发出来的。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240803014042af95aba9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240803014042af95aba9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INBX","BK4139"],"gpt_icon":0},{"id":"2454383947","title":"Inhibrx Biosciences, Inc.盘中异动 股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454383947","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454383947?lang=zh_cn&edition=full","pubTime":"2024-07-25 02:17","pubTimestamp":1721845078,"startTime":"0","endTime":"0","summary":"北京时间2024年07月25日02时17分，Inhibrx Biosciences, Inc.股票出现异动，股价急速跳水5.09%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，拥有一系列新型生物治疗候选药物，这些药物是使用其专有的模块化蛋白质工程平台而被开发出来的。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240725021758941fa34a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240725021758941fa34a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INBX"],"gpt_icon":0},{"id":"2453061199","title":"Inhibrx Biosciences, Inc.盘中异动 大幅拉升5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453061199","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453061199?lang=zh_cn&edition=full","pubTime":"2024-07-24 03:09","pubTimestamp":1721761769,"startTime":"0","endTime":"0","summary":"北京时间2024年07月24日03时09分，Inhibrx Biosciences, Inc.股票出现异动，股价急速上涨5.04%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，拥有一系列新型生物治疗候选药物，这些药物是使用其专有的模块化蛋白质工程平台而被开发出来的。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724030930af93b216&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724030930af93b216&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INBX","BK4139"],"gpt_icon":0},{"id":"2453084927","title":"Inhibrx Biosciences(INBX.US)获摩根大通证券公司首次覆盖，给予大市一致评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2453084927","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453084927?lang=zh_cn&edition=full","pubTime":"2024-07-23 18:31","pubTimestamp":1721730683,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["159848","399975","BK4139","INBX"],"gpt_icon":0},{"id":"2453717866","title":"Inhibrx Biosciences, Inc.盘中异动 临近收盘急速上涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453717866","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453717866?lang=zh_cn&edition=full","pubTime":"2024-07-23 03:50","pubTimestamp":1721677859,"startTime":"0","endTime":"0","summary":"北京时间2024年07月23日03时50分，Inhibrx Biosciences, Inc.股票出现异动，股价大幅拉升5.12%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，拥有一系列新型生物治疗候选药物，这些药物是使用其专有的模块化蛋白质工程平台而被开发出来的。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723035059af937708&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723035059af937708&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INBX","BK4139"],"gpt_icon":0},{"id":"2452616254","title":"Inhibrx Biosciences, Inc.盘中异动 大幅跳水5.14%报13.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452616254","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452616254?lang=zh_cn&edition=full","pubTime":"2024-07-18 00:29","pubTimestamp":1721233795,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日00时29分，Inhibrx Biosciences, Inc.股票出现异动，股价大幅跳水5.14%。截至发稿，该股报13.67美元/股，成交量4.1507万股，换手率0.29%，振幅5.20%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为2.00%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，拥有一系列新型生物治疗候选药物，这些药物是使用其专有的模块化蛋白质工程平台而被开发出来的。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718002955aefa2906&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718002955aefa2906&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INBX"],"gpt_icon":0},{"id":"2449294395","title":"Inhibrx Biosciences, Inc.盘中异动 临近午盘急速下挫5.02%报12.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449294395","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449294395?lang=zh_cn&edition=full","pubTime":"2024-07-05 23:36","pubTimestamp":1720193779,"startTime":"0","endTime":"0","summary":"北京时间2024年07月05日23时36分，Inhibrx Biosciences, Inc.股票出现波动，股价急速下挫5.02%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.95%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，拥有一系列新型生物治疗候选药物，这些药物是使用其专有的模块化蛋白质工程平台而被开发出来的。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705233619aef8302b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705233619aef8302b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INBX","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.inhibrx.com","stockEarnings":[{"period":"1week","weight":0.091},{"period":"1month","weight":-0.0332},{"period":"3month","weight":0.0472},{"period":"6month","weight":0.0675},{"period":"1year","weight":-0.0713},{"period":"ytd","weight":-0.0713}],"compareEarnings":[{"period":"1week","weight":0.0159},{"period":"1month","weight":0.0319},{"period":"3month","weight":0.0641},{"period":"6month","weight":0.1358},{"period":"1year","weight":0.3124},{"period":"ytd","weight":0.2571}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Inhibrx Biosciences, Inc.于2024年1月8日根据特拉华州法律成立，是Inhibrx, Inc.的直接全资子公司。该公司是一家临床阶段的生物制药公司，拥有一系列新型候选生物治疗药物，使用其专有的模块化蛋白质工程平台开发。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.100441},{"month":2,"riseRate":0,"avgChangeRate":-0.118883},{"month":3,"riseRate":0.25,"avgChangeRate":-0.108872},{"month":4,"riseRate":0.5,"avgChangeRate":-0.034815},{"month":5,"riseRate":0.25,"avgChangeRate":-0.039218},{"month":6,"riseRate":0.666667,"avgChangeRate":0.088726},{"month":7,"riseRate":0.666667,"avgChangeRate":0.111417},{"month":8,"riseRate":1,"avgChangeRate":0.030836},{"month":9,"riseRate":0.75,"avgChangeRate":0.016607},{"month":10,"riseRate":0.5,"avgChangeRate":0.197255},{"month":11,"riseRate":0.75,"avgChangeRate":0.223807},{"month":12,"riseRate":0.75,"avgChangeRate":0.232405}],"exchange":"NASDAQ","name":"Inhibrx Biosciences","nameEN":"Inhibrx Biosciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Inhibrx Biosciences(INBX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Inhibrx Biosciences(INBX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Inhibrx Biosciences,INBX,Inhibrx Biosciences股票,Inhibrx Biosciences股票老虎,Inhibrx Biosciences股票老虎国际,Inhibrx Biosciences行情,Inhibrx Biosciences股票行情,Inhibrx Biosciences股价,Inhibrx Biosciences股市,Inhibrx Biosciences股票价格,Inhibrx Biosciences股票交易,Inhibrx Biosciences股票购买,Inhibrx Biosciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Inhibrx Biosciences(INBX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Inhibrx Biosciences(INBX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}